-
A new ‘molecular lantern’ detects brain metastasis in mice
01 Jan 2025 10:48 GMT
… accurately detect diagnostic markers for brain metastases and monitor molecular changes associated … .”
A new approach to treat brain metastasis
Manuel Valiente, from the CNIO …
-
A new ‘molecular lantern’ detects brain metastasis in mice by inserting a probe thinner than a hair into the brain
31 Dec 2024 12:01 GMT
… as detecting diagnostic markers of brain metastasis with high accuracy,’ explain the … of the CSIC, and the Brain Metastasis Group of the CNIO directed …
-
Revolutionary Ultra-Thin Light Probe Enables Enhanced Detection of Brain Metastases in Mice
31 Dec 2024 10:44 GMT
… in experimental models focused on brain metastases, revealing how tumors release cells …
-
Satri-cel Improves PFS in CLDN18.2+ Advanced Gastric/GEJ Cancers
03 Jan 2025 17:57 GMT
… to enroll if they had brain metastasis, a high risk of hemorrhage …
-
Taletrectinib Approved in China for Locally Advanced/Metastatic ROS1+ NSCLC
03 Jan 2025 18:15 GMT
… -naive patients with measurable baseline brain metastases (n = 8), the confirmed IC …
-
FLAURA/FLAURA2 Regimens as Treatment Options for NSCLC
03 Jan 2025 01:19 GMT
… chemotherapy to the treatment] is brain metastasis, positive ctDNA, which is like … both had EGFR [mutations] and brain metastasis, so we discussed osimertinib alone … longer true once they have brain metastasis. Technically, their blood-brain barrier …
-
FDA Signals Potential for Standard Approval of Paxalisib in Glioblastoma
03 Jan 2025 01:42 GMT
… , including pediatric brain cancer and brain metastases. We have received orphan drug …
-
Savolitinib Plus Osimertinib Receives Priority Review in China for Pretreated EGFR+ NSCLC With a MET Amplification
02 Jan 2025 20:14 GMT
… , spinal cord compression, or active brain metastases prior to the start of …
-
European Commission Approves Lazertinib Plus Amivantamab in First-Line EGFR-Mutated NSCLC
02 Jan 2025 20:14 GMT
… advanced NSCLC, including those with brain metastases, compared to osimertinib monotherapy. This …
-
FDA Approves Tislelizumab in Combination With Chemotherapy for Gastric, Gastrosophageal Junction Adenocarcinoma
02 Jan 2025 17:32 GMT
… , active leptomeningeal disease or uncontrolled brain metastasis; a diagnosis of gastric or …